J. Kocks (Groningen, Netherlands), H. Pinnock (Edinburgh (Edinburgh), United Kingdom)
Withdrawal of inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: who is suitable for a trial of withdrawal?
T. Harries (London, United Kingdom), G. Gilworth (London, United Kingdom), M. Thomas (Southampton, United Kingdom), C. Corrigan (London, United Kingdom), P. Murphy (London, United Kingdom), N. Hart (London, United Kingdom), L. Hamilton (London, United Kingdom), P. White (London, United Kingdom)
|  |
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
O. Savran (Hvidovre, Denmark), N. Godtfredsen (Hvidovre, Denmark), T. Sørensen (Værløse, Denmark), C. Jensen (Præstø, Denmark), C. Suppli Ulrik (Hvidovre, Denmark)
| |
Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care.
P. White (London, United Kingdom), G. Gilworth (London, United Kingdom), M. Thomas (Southampton, United Kingdom), C. Corrigan (London, United Kingdom), P. Murphy (London, United Kingdom), N. Hart (London, United Kingdom), L. Hamilton (London, United Kingdom), T. Harries (London, United Kingdom)
| |
De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
C. de Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)
| |
Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?
G. Gilworth (London, United Kingdom), T. Harries (London, United Kingdom), M. Thomas (Southampton, United Kingdom), C. Corrigan ( London, United Kingdom), P. Murphy (London, United Kingdom), N. Hart (London, United Kingdom), L. Hamilton (London, United Kingdom), P. White (London, United Kingdom)
| |
Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK
M. Singh (Rugeley, United Kingdom), K. Singh (Cardiff, United Kingdom)
|  |
Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer?
Z. Tursun (Izmir, Turkey), D. Tatar (Izmir, Turkey), N. Aksel (Izmir, Turkey), A. Ayranci (Izmir, Turkey), A. Erbaycu (Izmir, Turkey), Y. Varol (Izmir, Turkey)
| |
Young women awareness concerning asthma management during pregnancy
S. Skoczynski (Katowice, Poland), G. Brozek (Katowice, Poland), A. Oraczewska (Katowice, Poland), E. Tobiczyk (Katowice, Poland), K. Gazda (Katowice, Poland), A. Barczyk (Katowice, Poland)
| |
COPD as a Risk Factor in Primary Care: A Canadian Retrospective Cohort Study
C. Lindeman (Edmonton, Canada), A. Pham (Edmonton, Canada), T. Williamson (Calgary , Canada), N. Drummond (Edmonton, Canada), A. Cave (Edmonton, Canada)
| |
Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
A. Touil (Tunis, Tunisia), F. Yangui (Tunis, Tunisia), S. Antit (Tunis, Tunisia), L. Zakhama (Tunis, Tunisia), S. Ben Youssef (Tunis, Tunisia), M. Charfi (Tunis, Tunisia)
| |
Cardiovascular risk detection in COPD
R. Böcskei (Budapest, Hungary), B. Benczúr (Szekszárd, Hungary), A. Bikov (Budapest, Hungary), C. Böcskei (Tatabánya, Hungary), A. Bohács (Budapest, Hungary), V. Müller (Budapest, Hungary)
| |
COPD patients with asthma, characteristics and risk of exacerbations
K. Lisspers (Uppsala, Sweden), M. Hogman (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), H. Hedenstrom (Uppsala, Sweden), K. Broms (Uppsala, Sweden), B. Stallberg (Uppsala, Sweden)
| |
Correlation of depression levels and quality of life with severity of disease in COPD patients - A cross sectional study
R. Takhar (KOTA, India), K. Sharma (mewat, India), A. Jain (gurugram, India), D. Sudan (gurugram, India), S. Taneja (gurugram, India)
| |
Gender aspect of comorbidities in COPD patients in primary care.
K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), A. Zharikov (Barnaul, Russian Federation), G. Ermachkova (Barnaul, Russian Federation), M. Nikolaeva (Barnaul, Russian Federation), E. Mukhtarova (Yoshkar-Ola, Russian Federation)
| |
Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), Y. Shoykhet (Barnaul, Russian Federation), I. Veytsman (Barnaul, Russian Federation), A. Balitskya (Barnaul, Russian Federation), S. Mikleyeva (Yoshkar-Ola, Russian Federation)
| |
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), A. Zharikov (Barnaul, Russian Federation), A. Balitskaya (Barnaul, Russian Federation), A. Denisova (Yoshkar-Ola, Russian Federation)
| |